2008Biaoji mianyi fenxi yu linchuangRequires access

Inhibitory Effects of Simvastatin on Oxidative Stress of Patients with Type 2 Diabetes Mellitus

Xiaomin Liu

Open publisher page 0 citations

Abstract

To study the effects of simvastatin on oxidative stress and blood lipid metabolism of patients with type 2 diabetes mellitus,168 diabetic patients were randomly divided into simvastatin group and placebo group.The serum levels of SOD and MDA,as well as the lipid profile in patients were observed before and after 12 weeks treatment,respectively.The results showed that the serum levels of SOD in diabetic patients before treatment were significantly lower,and whereas level of MDA was higher than that of controls(P0.05).The serum levels of SOD in patients after 12 weeks consecutive simvastatin treatment were significantly higher,and whereas the serum level of MDA was significantly lower than that of before the treatment(P0.05).There was no significant difference on the serum levels of SOD and MDA observed before and after treatment in the placebo group(P0.05).The serum levels of HDL-C in patients after treatment with simvastatin were higher,and while the serum levels of TG,TC,LDL-C and VLDL-C were significantly lower than that of before the treatment(P0.01).There was no significant difference on the profiles of lipids before and after treatment in the placebo group(P0.05).Therefore,the simvastatin could significantly inhibit oxidative stress provoked by hyperglycemia and had beneficial effects on the lipid homeostasis of diabetic patients.

About this research paper

What this paper is about

To study the effects of simvastatin on oxidative stress and blood lipid metabolism of patients with type 2 diabetes mellitus,168 diabetic patients were randomly divided into simvastatin group and placebo group.The serum levels of SOD and MDA,as well as the lipid profile in patients were observed before and after 12 weeks treatment,respectively.The results showed that the serum levels of SOD in diabetic patients before treatment were significantly lower,and whereas level of MDA was higher than that of controls(P0.05).The serum levels of SOD in patients after 12 weeks consecutive simvastatin treatment were significantly higher,and whereas the serum level of MDA was significantly lower than that of before the treatment(P0.05).There was no significant difference on the serum levels of SOD and MDA observed before and after treatment in the placebo group(P0.05).The serum levels of HDL-C in patients after treatment with simvastatin were higher,and while the serum levels of TG,TC,LDL-C and VLDL-C were significantly lower than that of before the treatment(P0.01).There was no significant difference on the profiles of lipids before and after treatment in the placebo group(P0.05).Therefore,the simvastatin could significantly inhibit oxidative stress provoked by hyperglycemia and had beneficial effects on the lipid homeostasis of diabetic patients.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

To study the effects of simvastatin on oxidative stress and blood lipid metabolism of patients with type 2 diabetes mellitus,168 diabetic patients were randomly divided into simvastatin group and placebo group.The serum levels of SOD and MDA,as well as the lipid profile in patients were observed before and after 12 weeks treatment,respectively.The results showed that the serum levels of SOD in diabetic patients before treatment were significantly lower,and whereas level of MDA was higher than that of controls(P0.05).The serum levels of SOD in patients after 12 weeks consecutive simvastatin treatment were significantly higher,and whereas the serum level of MDA was significantly lower than that of before the treatment(P0.05).There was no significant difference on the serum levels of SOD and MDA observed before and after treatment in the placebo group(P0.05).The serum levels of HDL-C in patients after treatment with simvastatin were higher,and while the serum levels of TG,TC,LDL-C and VLDL-C were significantly lower than that of before the treatment(P0.01).There was no significant difference on the profiles of lipids before and after treatment in the placebo group(P0.05).Therefore,the simvastatin could significantly inhibit oxidative stress provoked by hyperglycemia and had beneficial effects on the lipid homeostasis of diabetic patients.

Key concepts: Simvastatin, Medicine, Internal medicine, Oxidative stress, Placebo, Endocrinology, Diabetes mellitus, Lipid profile

Related papers

Back to paper searchBrowse research topicsOriginal source
Inhibitory Effects of Simvastatin on Oxidative Stress of Patients with Type 2 Diabetes Mellitus — Research Paper | ScholarLens